SOOIL Diabecare RS/AnyDana-i/AnyDana-A up to 2.x Bluetooth LE random values
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.2 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in SOOIL Diabecare RS, AnyDana-i and AnyDana-A up to 2.x and classified as problematic. Impacted is an unknown function of the component Bluetooth LE Handler. Performing a manipulation results in random values. This vulnerability is cataloged as CVE-2020-27264. The attack must originate from the local network. There is no exploit available. The affected component should be upgraded.
Details
A vulnerability classified as problematic has been found in SOOIL Diabecare RS, AnyDana-i and AnyDana-A up to 2.x (Medical Device Software). This affects an unknown part of the component Bluetooth LE Handler. The manipulation with an unknown input leads to a random values vulnerability. CWE is classifying the issue as CWE-330. The product uses insufficiently random numbers or values in a security context that depends on unpredictable numbers. This is going to have an impact on confidentiality.
The weakness was shared 01/20/2021 as icsma-21-012-01. The advisory is shared at us-cert.cisa.gov. This vulnerability is uniquely identified as CVE-2020-27264. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1600.001 for this issue.
Upgrading to version 3.0 eliminates this vulnerability.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.6VulDB Meta Temp Score: 6.4
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 8.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Random valuesCWE: CWE-330 / CWE-310
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Partially
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Diabecare RS/AnyDana-i/AnyDana-A 3.0
Timeline
10/19/2020 🔍01/20/2021 🔍
01/20/2021 🔍
02/15/2021 🔍
Sources
Advisory: icsma-21-012-01Status: Confirmed
CVE: CVE-2020-27264 (🔍)
GCVE (CVE): GCVE-0-2020-27264
GCVE (VulDB): GCVE-100-168129
Entry
Created: 01/20/2021 08:12Updated: 02/15/2021 15:34
Changes: 01/20/2021 08:12 (34), 01/20/2021 08:13 (6), 02/15/2021 15:28 (2), 02/15/2021 15:34 (18)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.